吗啡戒断对与前额叶皮层表达的TLR2通路相关的基因的影响
Bridget Truitt1, Junyi Tao1, Sabita Roy1
1Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Science progress
|September 4, 2024
概括
阿片类药物戒断症状会导致复发,但机制尚不清楚. 这项研究揭示了收费类受体2 (TLR2) 在吗啡戒断中发挥着关键作用,这表明它是潜在的治疗标.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿片类药物使用障碍 (OUD) 是一个主要的公共卫生危机,戒断症状对复发有重大影响.
- 目前缓解阿片类药物戒断的治疗选择有限,原因是对潜在机制的不完全理解.
- 之前的研究表明,吗啡诱导的微生物变化和由托尔类受体2 (TLR2) 介导的戒断反应之间存在联系.
研究的目的:
- 调查2号类似收费受体 (TLR2) 在吗啡戒断机制中的作用.
- 在吗啡戒断期间探索前额叶皮质的TLR2信号通路.
- 评估TLR2作为治疗治疗阿片类药物戒断的治疗标的潜力.
主要方法:
- 在吗啡戒断模型中对前额叶皮层的转录组分析.
- 在抗生素治疗后评估TLR2通路基因表达.
- 在全身TLR2淘汰赛小鼠模型中评估吗啡戒断效应.
主要成果:
- 在接受吗啡戒断的动物的前额皮质中观察到TLR2信号通路基因的表达增加.
- 抗生素治疗调节了与TLR2相关的基因表达,部分逆转了吗啡诱导的影响.
- 吗啡戒断诱导的基因表达变化在TLR2淘汰赛小鼠中显著减弱.
结论:
- 收费类受体2 (TLR2) 是吗啡戒断背后的机制的组成部分.
- 向TLR2可能提供一种新的治疗策略,以缓解阿片类药物戒断症状和相关的并发症.
- 对TLR2介导途径的进一步研究可能会导致改善阿片类药物使用障碍的治疗方法.
相关概念视频
Analgesia and Pain Management
552
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
552
Opioid Receptors: Overview
589
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
589
Opioid Analgesics: Morphine and Other Natural Cogeners
192
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
192
Opioid Analgesics: Synthetic and Semisynthetic Opioids
251
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
251
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena
448
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
448


